NZ
Therapeutic Areas
Seed Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ST-01156 | Ewing sarcoma, Hepatocellular carcinoma & other tumors | Phase 1 |
| Undisclosed Tau Degrader | Neurodegeneration | Lead ID |
| Partnered Program (Lilly/Eisai) | Undisclosed | Lead ID |
| Drug | Indication | Phase |
|---|---|---|
| ST-01156 | Ewing sarcoma, Hepatocellular carcinoma & other tumors | Phase 1 |
| Undisclosed Tau Degrader | Neurodegeneration | Lead ID |
| Partnered Program (Lilly/Eisai) | Undisclosed | Lead ID |